Literature DB >> 10075604

Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity.

B Kaplan1, K Lown, R Craig, M Abecassis, D Kaufman, J Leventhal, F Stuart, H U Meier-Kriesche, J Fryer.   

Abstract

With intestine transplants the allograft is dependent on itself for maintenance of adequate immunosuppression. We evaluated an intestinal transplant recipient who required very large doses of either tacrolimus or cyclosporine emulsion to achieve acceptable blood concentrations. Pharmacokinetic studies revealed bioavailabilities of 2% and 6% respectively, while D-xylose and B12 absorption were found to be within normal limits and fecal fat was only slightly increased, suggesting that there was a selective absorptive defect for these drugs. Biopsies of the allograft ileum revealed a high P-glycoprotein activity compared to the jejunum or to intestinal biopsies from other normal subjects. This may be a contributing factor to poor immunosuppressive drug absorption in this patient and others.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075604     DOI: 10.1097/00007890-199901270-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein content.

Authors:  Alan L Buchman; Mary F Paine; Anita Wallin; Shana S Ludington
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 2.  Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?

Authors:  H U Meier-Kriesche; B Kaplan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.

Authors:  Ai Mihara; Takehiko Mori; Yoshinobu Aisa; Rie Yamazaki; Osamu Iketani; Yusuke Tanigawara; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Eur J Clin Pharmacol       Date:  2007-10-28       Impact factor: 2.953

Review 6.  A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.

Authors:  Felix Krenzien; Abdallah ElKhal; Markus Quante; Hector Rodriguez Cetina Biefer; Uehara Hirofumi; Steven Gabardi; Stefan G Tullius
Journal:  Transplantation       Date:  2015-11       Impact factor: 4.939

7.  A novel nanocapsule delivery system to overcome intestinal degradation and drug transport limited absorption of P-glycoprotein substrate drugs.

Authors:  Taher Nassar; Alona Rom; Abraham Nyska; Simon Benita
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.